Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists discover new ‘jumping’ superbug gene
“In treatments, if colistin does not work, it literally could mean death for patients. If colistin resistance spreads, a lot of people will die.”
mcr-9 can cause resistance to colistin 

US food scientists have discovered mcr-9, a new ‘jumping gene’ that can cause resistance to the last resort antibiotic colistin.

Cornell University researchers found mcr-9 in the genome of a strain of salmonella. To their surprise, the salmonella strain did not show colistin resistance.

However, when the gene was inserted into a non-pathogenic strain of E coli, researchers were able to ‘turn on’ mcr-9, making the strain resistant to colistin.

The findings have been published in the journal Mbio.

Co-lead author Laura Carroll said: “When we originally tested the salmonella isolate and found that it wasn’t resistant to colistin, we were perplexed. But when [co-lead author Ahmed Gabella] cloned it into an E. coli host, he was able to find that the gene could confer resistance to colistin.”

Commenting on the findings, Professor Martin Wiedmann said: “In treatments, if colistin does not work, it literally could mean death for patients. If colistin resistance spreads, a lot of people will die.”

mcr-9 is the latest in a string of ‘mobilised colistin-resistance genes’ first discovered in 2015.

The National Centre for Biotechnology Information added details of the new gene to its database, so that it can be used to identify the gene in bacteria isolated from food and people.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.